TScan Therapeutics
TCRX
#7495
Rank
C$0.38 B
Marketcap
$7.32
Share price
4.13%
Change (1 day)
18.13%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -$3.91

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.00. In 2022 the company made an earnings per share (EPS) of -$3.80 a decrease over its 2021 EPS that were of -$3.01.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.912.75%
2022-$3.8026.25%
2021-$3.0199.58%
2020-$1.51